Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(S)-amphetamine
(+)-α-methylphenylethylamine
(S)-(+)-amphetamine
(+)-amphetamine
Dexamfetamine
Dextroamphetamine adipate
Dextroamphetamine
Dexamfetaminum
(S)-α-methylbenzeneethanamine
Dexanfetamina
(S)-1-phenyl-2-propylamine
(αS)-α-methylbenzeneethanamine
Dexamphetamine
(S)-(+)-β-phenylisopropylamine
Dextroamphetamine sulfate
Desamfetamina
(+)-α-methylphenethylamine
d-amphetamine
Dexamfetamina
(+)-(S)-amphetamine
Dextroamphetamine saccharate
(S)-1-phenyl-2-aminopropane
Brand Names
Dextrostat
Dextroamphetamine
PMS-dextroamphetamine
Zenzedi
Procentra
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Adderall
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
